|
Phase 1 Pharmacokinetic (PK) Assessment of ATI-1123, a Novel Human Serum Albumin-Stabilized Nanoparticle Docetaxel Liposomal Formulation, in Patients with Advanced Solid Malignancies |
 |
 |
 |
|
November 2011
Azaya Therapeutics, Inc. Scientific Posters showcased at the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics
Download PDF Poster 1
Download PDF Poster 2 |
|
|
Azaya Therapeutics Announces the Addition of Two New Board Members |
|
|
|
|
April 2011
Dear Stockholders -We are very pleased to announce the addition of two new Board members to the Azaya Therapeutics Board of Directors. Both Dr. Joseph P. Miller and Dr. Gary West have extensive experience in treating cancer patients and their advice and council will be important to Azaya Therapeutics as we advance our two current products through clinical development.
|
|
Read more...
|
|
Rice Alliance Announces Most Promising Life Science Companies at 2011 Life Science Technology Venture Forum |
|
|
|
|
Originally Posted on Rice Alliance
Monday, June 20, 2011
HOUSTON – (June 20, 2011)- The Rice Alliance for Technology and Entrepreneurship (Rice Alliance) announced the five Most Promising Life Science Technology companies and five Rising Ventures at the 10th Annual Life Science Technology Venture Forum in Houston last Thursday. Life Science Technology companies showcased their new offerings at the largest venture capital conference in the Southwest with 350 attendees, including investors, venture capitalists, industry representatives, business leaders, service providers, and entrepreneurs.
|
|
Read more...
|
|
Azaya Therapeutics Presents Phase I Data at ASCO and Completes Offering |
|
|
|
|
Monday, June 6, 2011
-
Phase I study conducted at two premier cancer research facilities in Texas
-
$3.5 million convertible debt offering closed
SAN ANTONIO, Texas – Azaya Therapeutics, Inc. presented data from its ongoing Phase I study of ATI-1123 today at the annual meeting of the American Society of Clinical Oncology held in Chicago, IL.
|
|
Read more...
|
|
Azaya Sells More Than $3 Million in Debt in Private Placement |
|
|
|
|
Monday, June 6, 2011
Azaya Therapeutics Inc. has completed a new round of private investment by raising $3.5 million through the issuance of 5-percent convertible notes sold to investors.
|
|
Read more...
|
|
|
|
|
|
